Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
AMED Hot Sheet
Rating Summary:0 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 7 | New: 22
Stifel Nicolaus upgrades Amedisys (Nasdaq: AMED) from Hold to Buy.
To see more analyst ratings on AMED Click Here.
Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population.
To see more analyst ratings on AMED Click Here.
Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population.
You May Also Be Interested In
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- Macquarie Upgrades SBA Communications (SBAC) to Outperform
- Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
Create E-mail Alert Related Categories
UpgradesRelated Entities
Stifel NicolausSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
